The CIMP phenotype in BRAF mutant serrated polyps from a prospective colonoscopy patient cohort

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Fernando, Winnie C ^a,b   Miranda, Mariska S ^a,c   Worthley, Daniel L ^a   Togashi, Kazutomo ^d   Watters, Dianne J ^b   Leggett, Barbara A ^a,c,e   Spring, Kevin J ^a,b,f  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; MUTANT PROTEIN; PROTEIN MLH1; PROTEIN P16; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASCENDING COLON; COHORT ANALYSIS; COLON ADENOMA; COLON POLYP; COLONOSCOPY; CPG ISLAND; CPG ISLAND METHYLATOR PHENOTYPE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PHENOTYPE; PROSPECTIVE STUDY; PROTEIN METHYLATION; RECTUM ADENOMA;

EID: 84900308142     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/374926     Document Type: Article

References (41)

1. Konishi F., Morson B. C., Pathology of colorectal adenomas: a colonoscopic survey. Journal of Clinical Pathology 1982 35 8 830 841 2-s2.0-0019960920 (Pubitemid 12048799)
2. Rubio C. A., Colorectal adenomas: time for reappraisal. Pathology Research and Practice 2002 198 9 615 620 2-s2.0-0036030064 (Pubitemid 35244059)
3. Fearon E. R., Vogelstein B., A genetic model for colorectal tumorigenesis. Cell 1990 61 5 759 767 2-s2.0-0025312728 10.1016/0092-8674(90) 90186-I (Pubitemid 20185636)
4. Hill M. J., Morson B. C., Bussey H. J. R., Aetiology of adenoma carcinoma sequence in large bowel. The Lancet 1978 1 8058 245 247 2-s2.0-0017877751 (Pubitemid 8268162)
5. Fenoglio C. M., Lane N., The anatomical precursor of colorectal carcinoma. Cancer 1974 34 3 819 823 2-s2.0-0016176940
6. Cooper H. S., Patchefsky A. S., Marks G. A. S., Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Diseases of the Colon and Rectum 1979 22 3 152 156 2-s2.0-0018748069 (Pubitemid 9196208)
7. Makinen M. J., George S. M., Jernvall P., Makela J., Vihko P., Karttunen T. J., Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. Journal of Pathology 2001 193 3 286 294 (Pubitemid 32229858)
8. O'Brien M. J., Yang S., Mack C., Xu H., Huang C. S., Mulcahy E., Amorosino M., Farraye F. A., Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. American Journal of Surgical Pathology 2006 30 12 1491 1501 2-s2.0-33751320353 10.1097/01.pas.0000213313.36306.85 (Pubitemid 44808785)
9. Torlakovic E., Skovlund E., Snover D. C., Torlakovic G., Nesland J. M., Morphologic reappraisal of serrated colorectal polyps. American Journal of Surgical Pathology 2003 27 1 65 81 2-s2.0-0037216302 10.1097/00000478-200301000- 00008 (Pubitemid 36014900)
10. Snover D. C., Update on the serrated pathway to colorectal carcinoma. Human Pathology 2011 42 1 1 10 2-s2.0-78649985198 10.1016/j.humpath.2010.06.002
11. Thibodeau S. N., French A. J., Cunningham J. M., Tester D., Burgart L. J., Roche P. C., McDonnell S. K., Schaid D. J., Vockley C. W., Michels V. V., Farr G. H. Jr., O'Connell M. J., Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Research 1998 58 8 1713 1718 2-s2.0-0032522658 (Pubitemid 28215098)
12. Davies H., Bignell G. R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M. J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B. A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G. J., Bigner D. D., Palmleri G., Cossu A., Flanagan A., Nicholson A., Ho J. W. C., Leung S. Y., Yuen S. T., Weber B. L., Seigler H. F., Darrow T. L., Paterson H., Marais R., Marshall C. J., Wooster R., Stratton M. R., Futreal P. A., Mutations of the BRAF gene in human cancer. Nature 2002 417 6892 949 954 2-s2.0-18444374405 10.1038/nature00766 (Pubitemid 34716871)
13. Toyota M., Ahuja N., Ohe-Toyota M., Herman J. G., Baylin S. B., Issa J.-P. J., CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 1999 96 15 8681 8686 2-s2.0-0033587747 10.1073/pnas.96.15.8681 (Pubitemid 29354851)
14. Kim Y.-H., Petko Z., Dzieciatkowski S., Lin L., Ghiassi M., Stain S., Chapman W. C., Washington M. K., Willis J., Markowitz S. D., Grady W. M., CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes and Cancer 2006 45 8 781 789 2-s2.0-33745714364 10.1002/gcc.20341
15. Barault L., Charon-Barra C., Jooste V., De La Vega M. F., Martin L., Roignot P., Rat P., Bouvier A.-M., Laurent-Puig P., Faivre J., Chapusot C., Piard F., Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Research 2008 68 20 8541 8546 2-s2.0-54249165951 10.1158/0008-5472.CAN-08-1171
16. Hinoue T., Weisenberger D. J., Pan F., Campan M., Kim M., Young J., Whitehall V. L., Leggett B. A., Laird P. W., Analysis of the association between CIMP and BRAFV600Ein colorectal cancer by DNA methylation profiling. PLoS ONE 2009 4 12 2-s2.0-77249141762 10.1371/journal.pone.0008357 e8357
17. Weisenberger D. J., Siegmund K. D., Campan M., Young J., Long T. I., Faasse M. A., Kang G. H., Widschwendter M., Weener D., Buchanan D., Koh H., Simms L., Barker M., Leggett B., Levine J., Kim M., French A. J., Thibodeau S. N., Jass J., Haile R., Laird P. W., CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 2006 38 7 787 793 2-s2.0-33745541234 10.1038/ng1834 (Pubitemid 43980599)
18. Eads C. A., Danenberg K. D., Kawakami K., Saltz L. B., Blake C., Shibata D., Danenberg P. V., Laird P. W., MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Research 2000 28 8, article E32 2-s2.0-0034654669
19. O'Brien M. J., Yang S., Clebanoff J. L., Mulcahy E., Farraye F. A., Amorosino M., Swan N., Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. American Journal of Surgical Pathology 2004 28 4 423 434 2-s2.0-1842529801 10.1097/00000478-200404000-00001 (Pubitemid 38436515)
20. Spring K. J., Zhao Z. Z., Karamatic R., Walsh M. D., Whitehall V. L. J., Pike T., Simms L. A., Young J., James M., Montgomery G. W., Appleyard M., Hewett D., Togashi K., Jass J. R., Leggett B. A., High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006 131 5 1400 1407 2-s2.0-33750682008 10.1053/j.gastro.2006.08.038 (Pubitemid 44708940)
21. Bettington M., Walker N., Clouston A., Brown I., Leggett B., Whitehall V., The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013 62 3 367 386
22. Bird A. P., CpG-rich islands and the function of DNA methylation. Nature 1986 321 6067 209 213 2-s2.0-0022540321 (Pubitemid 16016411)
23. Lee S., Cho N.-Y., Choi M., Yoo E. J., Kim J.-H., Kang G. H., Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathology International 2008 58 2 104 113 2-s2.0-38149135181 10.1111/j.1440-1827.2007.02197.x
24. Park S.-J., Rashid A., Lee J.-H., Kim S. G., Hamilton S. R., Wu T.-T., Frequent CpG island methylation in serrated adenomas of the colorectum. American Journal of Pathology 2003 162 3 815 822 2-s2.0-0037372340 (Pubitemid 36237490)
25. Kakar S., Deng G., Cun L., Sahai V., Kim Y. S., CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Human Pathology 2008 39 1 30 36 2-s2.0-36749036049 10.1016/j.humpath.2007.06.002 (Pubitemid 350216171)
26. Pai R. K., MacKinnon A. C., Joseph L., Noffsinger A., Hart J., Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. American Journal of Surgical Pathology 2010 34 3 355 363 2-s2.0-77649199225 10.1097/PAS. 0b013e3181c6b9dd
27. Vaughn C. P., Wilson A. R., Samowitz W. S., Quantitative evaluation of CpG island methylation in hyperplastic polyps. Modern Pathology 2010 23 1 151 156 2-s2.0-73949134204 10.1038/modpathol.2009.150
28. Sandmeier D., Benhattar J., Martin P., Bouzourene H., Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology 2009 55 2 206 213 2-s2.0-68749109876 10.1111/j.1365-2559.2009.03356.x
29. Yang S., Farraye F. A., Mack C., Posnik O., O'Brien M. J., BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. American Journal of Surgical Pathology 2004 28 11 1452 1459 2-s2.0-7044253667 10.1097/01.pas. 0000141404.56839.6a (Pubitemid 39425511)
30. Gaiser T., Meinhardt S., Hirsch D., Killian J. K., Gaedcke J., Jo P., Ponsa I., Miro R., Ruschoff J., Seitz G., Hu Y., Camps J., Ried T., Molecular patterns in the evolution of serrated lesion of the colorectum. International Journal of Cancer 2013 132 8 1800 1810
31. Burnett-Hartman A. N., Newcomb P. A., Potter J. D., Passarelli M. N., Phipps A. I., Wurscher M. A., Grady W. M., Zhu L. C., Upton M. P., Makar K. W., Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Research 2013 73 9 2863 2872
32. Kim K.-M., Lee E. J., Ha S., Kang S. Y., Jang K.-T., Park C. K., Kim J. Y., Kim Y. H., Chang D. K., Odze R. D., Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. American Journal of Surgical Pathology 2011 35 9 1274 1286 2-s2.0-80052348969 10.1097/PAS.0b013e318224cd2e
33. Maeda T., Suzuki K., Togashi K., Nokubi M., Saito M., Tsujinaka S., Kamiyama H., Konishi F., Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner. Experimental and Therapeutic Medicine 2011 2 4 695 700 2-s2.0-79958058741 10.3892/etm.2011.249
34. Miyakura Y., Sugano K., Konishi F., Ichikawa A., Maekawa M., Shitoh K., Igarashi S., Kotake K., Koyama Y., Nagai H., Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 2001 121 6 1300 1309 2-s2.0-0035213535 (Pubitemid 33140447)
35. Yong H. K., Kakar S., Cun L., Deng G., Kim Y. S., Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. International Journal of Cancer 2008 123 11 2587 2593 2-s2.0-57349089198 10.1002/ijc.23840
36. Dong S. M., Lee E. J., Jeon E. S., Park C. K., Kim K.-M., Progressive methylation during the serrated neoplasia pathway of the colorectum. Modern Pathology 2005 18 2 170 178 2-s2.0-13244264729 10.1038/modpathol.3800261 (Pubitemid 40188623)
37. Toyota M., Ohe-Toyota M., Ahuja N., Issa J.-P. J., Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proceedings of the National Academy of Sciences of the United States of America 2000 97 2 710 715 2-s2.0-0034681117 10.1073/pnas.97.2.710 (Pubitemid 30070374)
38. Psofaki V., Kalogera C., Tzambouras N., Stephanou D., Tsianos E., Seferiadis K., Kolios G., Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. World Journal of Gastroenterology 2010 16 28 3553 3560 2-s2.0-77955116053 10.3748/wjg.v16.i28.3553
39. Dhir M., Yachida S., Neste L. V., Glöckner S. C., Jeschke J., Pappou E. P., Montgomery E. A., Herman J. G., Baylin S. B., Iacobuzio-Donahue C., Ahuja N., Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. International Journal of Cancer 2011 129 8 1889 1898 2-s2.0-80052034907 10.1002/ijc.25847
40. Suzuki H., Igarashi S., Nojima M., Maruyama R., Yamamoto E., Kai M., Akashi H., Watanabe Y., Yamamoto H., Sasaki Y., Itoh F., Imai K., Sugai T., Shen L., Issa J.-P. J., Shinomura Y., Tokino T., Toyota M., IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 2010 31 3 342 349 2-s2.0-77950900898 10.1093/carcin/bgp179
41. Kaji E., Uraoka T., Kato J., Hiraoka S., Suzuki H., Akita M., Saito S., Tanaka T., Ohara N., Yamamoto K., Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7. Digestive Diseases and Sciences 2012 57 5 1261 1270 2-s2.0-83355164893 10.1007/s10620-011-2008-0